ReviewMedical oncology (Northwood, London, England)2020

NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials.

Zainul Abedin Kapacee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.